BMY
Bristol-Myers Squibb Co
Price:  
41.54 
USD
Volume:  
12,431,083.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy WACC - Weighted Average Cost of Capital

The WACC of Bristol-Myers Squibb Co (BMY) is 6.0%.

The Cost of Equity of Bristol-Myers Squibb Co (BMY) is 7.15%.
The Cost of Debt of Bristol-Myers Squibb Co (BMY) is 4.30%.

Range Selected
Cost of equity 6.30% - 8.00% 7.15%
Tax rate 16.00% - 22.80% 19.40%
Cost of debt 4.00% - 4.60% 4.30%
WACC 5.4% - 6.7% 6.0%
WACC

Bmy WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.53 0.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.00%
Tax rate 16.00% 22.80%
Debt/Equity ratio 0.45 0.45
Cost of debt 4.00% 4.60%
After-tax WACC 5.4% 6.7%
Selected WACC 6.0%